nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—HRH2—coronary artery disease	0.267	0.555	CbGaD
Loxapine—HTR7—coronary artery disease	0.091	0.189	CbGaD
Loxapine—ADRB1—coronary artery disease	0.0779	0.162	CbGaD
Loxapine—HTR1B—Penbutolol—coronary artery disease	0.0604	0.338	CbGbCtD
Loxapine—ADRB1—Penbutolol—coronary artery disease	0.0473	0.264	CbGbCtD
Loxapine—HTR2A—coronary artery disease	0.0457	0.0949	CbGaD
Loxapine—HTR1A—Penbutolol—coronary artery disease	0.0378	0.212	CbGbCtD
Loxapine—ADRB1—Timolol—coronary artery disease	0.0333	0.186	CbGbCtD
Loxapine—HTR3A—vagus nerve—coronary artery disease	0.00322	0.0751	CbGeAlD
Loxapine—SLC6A2—sympathetic nervous system—coronary artery disease	0.00223	0.052	CbGeAlD
Loxapine—HTR7—pulmonary artery—coronary artery disease	0.00221	0.0516	CbGeAlD
Loxapine—HTR7—sympathetic nervous system—coronary artery disease	0.00215	0.0502	CbGeAlD
Loxapine—HTR2A—arteriole—coronary artery disease	0.0021	0.0491	CbGeAlD
Loxapine—HTR7—vagus nerve—coronary artery disease	0.00208	0.0486	CbGeAlD
Loxapine—HTR7—vein—coronary artery disease	0.00201	0.0469	CbGeAlD
Loxapine—SLC6A2—autonomic nervous system—coronary artery disease	0.0015	0.035	CbGeAlD
Loxapine—HTR7—autonomic nervous system—coronary artery disease	0.00144	0.0337	CbGeAlD
Loxapine—HTR2A—pulmonary artery—coronary artery disease	0.00138	0.0322	CbGeAlD
Loxapine—HTR2A—sympathetic nervous system—coronary artery disease	0.00134	0.0313	CbGeAlD
Loxapine—HTR2A—vagus nerve—coronary artery disease	0.0013	0.0303	CbGeAlD
Loxapine—HTR2A—vein—coronary artery disease	0.00125	0.0293	CbGeAlD
Loxapine—HTR1B—artery—coronary artery disease	0.00106	0.0248	CbGeAlD
Loxapine—HRH4—blood—coronary artery disease	0.00105	0.0246	CbGeAlD
Loxapine—HTR1D—artery—coronary artery disease	0.00103	0.024	CbGeAlD
Loxapine—DRD4—heart—coronary artery disease	0.000959	0.0224	CbGeAlD
Loxapine—HTR2A—autonomic nervous system—coronary artery disease	0.0009	0.021	CbGeAlD
Loxapine—Cyclizine—SULT1E1—coronary artery disease	0.000834	0.219	CrCbGaD
Loxapine—HTR7—artery—coronary artery disease	0.000819	0.0191	CbGeAlD
Loxapine—HTR7—endothelium—coronary artery disease	0.000692	0.0162	CbGeAlD
Loxapine—Asenapine—HRH2—coronary artery disease	0.000637	0.168	CrCbGaD
Loxapine—HRH2—heart—coronary artery disease	0.000593	0.0139	CbGeAlD
Loxapine—ADRB1—cardiac ventricle—coronary artery disease	0.00056	0.0131	CbGeAlD
Loxapine—HRH2—cardiovascular system—coronary artery disease	0.00056	0.0131	CbGeAlD
Loxapine—ADRB1—myocardium—coronary artery disease	0.000527	0.0123	CbGeAlD
Loxapine—HTR2A—artery—coronary artery disease	0.000511	0.0119	CbGeAlD
Loxapine—HRH2—cardiac atrium—coronary artery disease	0.000507	0.0118	CbGeAlD
Loxapine—HRH2—blood—coronary artery disease	0.000443	0.0103	CbGeAlD
Loxapine—HTR2A—endothelium—coronary artery disease	0.000431	0.0101	CbGeAlD
Loxapine—ADRA2C—cardiac ventricle—coronary artery disease	0.000422	0.00986	CbGeAlD
Loxapine—ADRA2C—myocardium—coronary artery disease	0.000397	0.00927	CbGeAlD
Loxapine—CHRM2—heart—coronary artery disease	0.000389	0.00908	CbGeAlD
Loxapine—HTR1B—cardiovascular system—coronary artery disease	0.000369	0.00862	CbGeAlD
Loxapine—ADRB1—heart—coronary artery disease	0.000368	0.00859	CbGeAlD
Loxapine—CHRM2—cardiovascular system—coronary artery disease	0.000367	0.00857	CbGeAlD
Loxapine—HTR1D—cardiovascular system—coronary artery disease	0.000357	0.00834	CbGeAlD
Loxapine—Olanzapine—HRH2—coronary artery disease	0.000354	0.0932	CrCbGaD
Loxapine—HTR3A—blood—coronary artery disease	0.000348	0.00812	CbGeAlD
Loxapine—ADRB1—cardiovascular system—coronary artery disease	0.000347	0.00811	CbGeAlD
Loxapine—CHRM1—cardiovascular system—coronary artery disease	0.000334	0.0078	CbGeAlD
Loxapine—ADRB1—cardiac atrium—coronary artery disease	0.000315	0.00735	CbGeAlD
Loxapine—HTR7—heart—coronary artery disease	0.000302	0.00704	CbGeAlD
Loxapine—HTR1A—cardiovascular system—coronary artery disease	0.000298	0.00695	CbGeAlD
Loxapine—ADRA1A—heart—coronary artery disease	0.000291	0.00679	CbGeAlD
Loxapine—HTR7—cardiovascular system—coronary artery disease	0.000285	0.00664	CbGeAlD
Loxapine—ADRA2C—heart—coronary artery disease	0.000277	0.00647	CbGeAlD
Loxapine—ADRA1A—cardiovascular system—coronary artery disease	0.000274	0.00641	CbGeAlD
Loxapine—SLC6A4—blood—coronary artery disease	0.000265	0.00619	CbGeAlD
Loxapine—ADRA2C—cardiac atrium—coronary artery disease	0.000237	0.00554	CbGeAlD
Loxapine—HTR7—blood—coronary artery disease	0.000225	0.00526	CbGeAlD
Loxapine—ADRA2A—heart—coronary artery disease	0.000221	0.00516	CbGeAlD
Loxapine—ADRA1A—blood—coronary artery disease	0.000217	0.00507	CbGeAlD
Loxapine—Asenapine—HTR7—coronary artery disease	0.000217	0.057	CrCbGaD
Loxapine—ADRA2C—blood—coronary artery disease	0.000207	0.00483	CbGeAlD
Loxapine—ADRA2A—cardiac atrium—coronary artery disease	0.000189	0.00442	CbGeAlD
Loxapine—HTR2A—heart—coronary artery disease	0.000188	0.00439	CbGeAlD
Loxapine—Asenapine—ADRB1—coronary artery disease	0.000186	0.0488	CrCbGaD
Loxapine—HTR2A—cardiovascular system—coronary artery disease	0.000177	0.00414	CbGeAlD
Loxapine—ADRA2A—blood—coronary artery disease	0.000165	0.00385	CbGeAlD
Loxapine—Asenapine—ADRB2—coronary artery disease	0.000156	0.0411	CrCbGaD
Loxapine—HTR2A—blood—coronary artery disease	0.00014	0.00328	CbGeAlD
Loxapine—Olanzapine—HTR7—coronary artery disease	0.00012	0.0317	CrCbGaD
Loxapine—Asenapine—HTR2A—coronary artery disease	0.000109	0.0287	CrCbGaD
Loxapine—Somnolence—Perindopril—coronary artery disease	0.000102	0.000733	CcSEcCtD
Loxapine—Feeling abnormal—Trandolapril—coronary artery disease	0.000102	0.000733	CcSEcCtD
Loxapine—Fatigue—Captopril—coronary artery disease	0.000102	0.000732	CcSEcCtD
Loxapine—Feeling abnormal—Enalapril—coronary artery disease	0.000102	0.00073	CcSEcCtD
Loxapine—Syncope—Ramipril—coronary artery disease	0.000102	0.000729	CcSEcCtD
Loxapine—Leukopenia—Ramipril—coronary artery disease	0.000102	0.000727	CcSEcCtD
Loxapine—Asthenia—Simvastatin—coronary artery disease	0.000101	0.000727	CcSEcCtD
Loxapine—Constipation—Captopril—coronary artery disease	0.000101	0.000726	CcSEcCtD
Loxapine—Tension—Lisinopril—coronary artery disease	0.000101	0.000723	CcSEcCtD
Loxapine—Hypotension—Losartan—coronary artery disease	0.000101	0.000723	CcSEcCtD
Loxapine—Dysgeusia—Lisinopril—coronary artery disease	0.000101	0.000722	CcSEcCtD
Loxapine—Dizziness—Clopidogrel—coronary artery disease	0.000101	0.000721	CcSEcCtD
Loxapine—Paraesthesia—Furosemide—coronary artery disease	0.0001	0.00072	CcSEcCtD
Loxapine—Feeling abnormal—Telmisartan—coronary artery disease	0.0001	0.00072	CcSEcCtD
Loxapine—Pruritus—Simvastatin—coronary artery disease	0.0001	0.000717	CcSEcCtD
Loxapine—Dizziness—Lovastatin—coronary artery disease	9.99e-05	0.000716	CcSEcCtD
Loxapine—Loss of consciousness—Ramipril—coronary artery disease	9.97e-05	0.000714	CcSEcCtD
Loxapine—Somnolence—Furosemide—coronary artery disease	9.95e-05	0.000713	CcSEcCtD
Loxapine—Syncope—Timolol—coronary artery disease	9.94e-05	0.000712	CcSEcCtD
Loxapine—Gastrointestinal disorder—Perindopril—coronary artery disease	9.93e-05	0.000712	CcSEcCtD
Loxapine—Fatigue—Perindopril—coronary artery disease	9.92e-05	0.000711	CcSEcCtD
Loxapine—Cough—Ramipril—coronary artery disease	9.9e-05	0.000709	CcSEcCtD
Loxapine—Muscle spasms—Lisinopril—coronary artery disease	9.89e-05	0.000709	CcSEcCtD
Loxapine—Constipation—Perindopril—coronary artery disease	9.84e-05	0.000705	CcSEcCtD
Loxapine—Vomiting—Fenofibrate—coronary artery disease	9.84e-05	0.000705	CcSEcCtD
Loxapine—Hypersensitivity—Valsartan—coronary artery disease	9.83e-05	0.000705	CcSEcCtD
Loxapine—Convulsion—Ramipril—coronary artery disease	9.83e-05	0.000704	CcSEcCtD
Loxapine—Dizziness—Ezetimibe—coronary artery disease	9.8e-05	0.000702	CcSEcCtD
Loxapine—Feeling abnormal—Captopril—coronary artery disease	9.77e-05	0.0007	CcSEcCtD
Loxapine—Insomnia—Losartan—coronary artery disease	9.76e-05	0.0007	CcSEcCtD
Loxapine—Rash—Fenofibrate—coronary artery disease	9.76e-05	0.000699	CcSEcCtD
Loxapine—Dermatitis—Fenofibrate—coronary artery disease	9.75e-05	0.000699	CcSEcCtD
Loxapine—Loss of consciousness—Timolol—coronary artery disease	9.74e-05	0.000698	CcSEcCtD
Loxapine—Headache—Fenofibrate—coronary artery disease	9.69e-05	0.000695	CcSEcCtD
Loxapine—Vision blurred—Lisinopril—coronary artery disease	9.69e-05	0.000695	CcSEcCtD
Loxapine—Paraesthesia—Losartan—coronary artery disease	9.69e-05	0.000695	CcSEcCtD
Loxapine—Cough—Timolol—coronary artery disease	9.67e-05	0.000693	CcSEcCtD
Loxapine—Vomiting—Clopidogrel—coronary artery disease	9.67e-05	0.000693	CcSEcCtD
Loxapine—Gastrointestinal disorder—Furosemide—coronary artery disease	9.66e-05	0.000692	CcSEcCtD
Loxapine—Chest pain—Ramipril—coronary artery disease	9.65e-05	0.000692	CcSEcCtD
Loxapine—Fatigue—Furosemide—coronary artery disease	9.64e-05	0.000691	CcSEcCtD
Loxapine—Tremor—Lisinopril—coronary artery disease	9.64e-05	0.000691	CcSEcCtD
Loxapine—Dyspnoea—Losartan—coronary artery disease	9.62e-05	0.00069	CcSEcCtD
Loxapine—Vomiting—Lovastatin—coronary artery disease	9.61e-05	0.000688	CcSEcCtD
Loxapine—Somnolence—Losartan—coronary artery disease	9.6e-05	0.000688	CcSEcCtD
Loxapine—Dizziness—Eplerenone—coronary artery disease	9.59e-05	0.000687	CcSEcCtD
Loxapine—Amoxapine—HTR7—coronary artery disease	9.59e-05	0.0252	CrCbGaD
Loxapine—Rash—Clopidogrel—coronary artery disease	9.59e-05	0.000687	CcSEcCtD
Loxapine—Dermatitis—Clopidogrel—coronary artery disease	9.58e-05	0.000687	CcSEcCtD
Loxapine—Asthenia—Valsartan—coronary artery disease	9.58e-05	0.000686	CcSEcCtD
Loxapine—Hypertension—Timolol—coronary artery disease	9.57e-05	0.000686	CcSEcCtD
Loxapine—Constipation—Furosemide—coronary artery disease	9.57e-05	0.000686	CcSEcCtD
Loxapine—Hypersensitivity—Niacin—coronary artery disease	9.56e-05	0.000685	CcSEcCtD
Loxapine—Asthenia—Olmesartan—coronary artery disease	9.53e-05	0.000683	CcSEcCtD
Loxapine—Headache—Clopidogrel—coronary artery disease	9.53e-05	0.000683	CcSEcCtD
Loxapine—Rash—Lovastatin—coronary artery disease	9.53e-05	0.000683	CcSEcCtD
Loxapine—Dermatitis—Lovastatin—coronary artery disease	9.52e-05	0.000682	CcSEcCtD
Loxapine—Feeling abnormal—Perindopril—coronary artery disease	9.48e-05	0.00068	CcSEcCtD
Loxapine—Headache—Lovastatin—coronary artery disease	9.47e-05	0.000678	CcSEcCtD
Loxapine—Pruritus—Valsartan—coronary artery disease	9.44e-05	0.000677	CcSEcCtD
Loxapine—Dry mouth—Ramipril—coronary artery disease	9.44e-05	0.000677	CcSEcCtD
Loxapine—Chest pain—Timolol—coronary artery disease	9.44e-05	0.000676	CcSEcCtD
Loxapine—Vomiting—Ezetimibe—coronary artery disease	9.42e-05	0.000675	CcSEcCtD
Loxapine—Hypersensitivity—Pravastatin—coronary artery disease	9.41e-05	0.000675	CcSEcCtD
Loxapine—Pruritus—Olmesartan—coronary artery disease	9.4e-05	0.000673	CcSEcCtD
Loxapine—Dizziness—Simvastatin—coronary artery disease	9.35e-05	0.00067	CcSEcCtD
Loxapine—Rash—Ezetimibe—coronary artery disease	9.34e-05	0.00067	CcSEcCtD
Loxapine—Dermatitis—Ezetimibe—coronary artery disease	9.34e-05	0.000669	CcSEcCtD
Loxapine—Confusional state—Ramipril—coronary artery disease	9.33e-05	0.000669	CcSEcCtD
Loxapine—Asthenia—Niacin—coronary artery disease	9.31e-05	0.000667	CcSEcCtD
Loxapine—Fatigue—Losartan—coronary artery disease	9.31e-05	0.000667	CcSEcCtD
Loxapine—Headache—Ezetimibe—coronary artery disease	9.28e-05	0.000665	CcSEcCtD
Loxapine—Oedema—Ramipril—coronary artery disease	9.26e-05	0.000663	CcSEcCtD
Loxapine—Dry mouth—Timolol—coronary artery disease	9.23e-05	0.000661	CcSEcCtD
Loxapine—Constipation—Losartan—coronary artery disease	9.23e-05	0.000661	CcSEcCtD
Loxapine—Syncope—Lisinopril—coronary artery disease	9.22e-05	0.000661	CcSEcCtD
Loxapine—Vomiting—Eplerenone—coronary artery disease	9.22e-05	0.000661	CcSEcCtD
Loxapine—Feeling abnormal—Furosemide—coronary artery disease	9.22e-05	0.000661	CcSEcCtD
Loxapine—Leukopenia—Lisinopril—coronary artery disease	9.21e-05	0.00066	CcSEcCtD
Loxapine—Nausea—Fenofibrate—coronary artery disease	9.19e-05	0.000659	CcSEcCtD
Loxapine—Pruritus—Niacin—coronary artery disease	9.18e-05	0.000658	CcSEcCtD
Loxapine—Asthenia—Pravastatin—coronary artery disease	9.17e-05	0.000657	CcSEcCtD
Loxapine—Rash—Eplerenone—coronary artery disease	9.15e-05	0.000655	CcSEcCtD
Loxapine—Hypersensitivity—Trandolapril—coronary artery disease	9.14e-05	0.000655	CcSEcCtD
Loxapine—Dermatitis—Eplerenone—coronary artery disease	9.14e-05	0.000655	CcSEcCtD
Loxapine—Confusional state—Timolol—coronary artery disease	9.12e-05	0.000654	CcSEcCtD
Loxapine—Shock—Ramipril—coronary artery disease	9.11e-05	0.000653	CcSEcCtD
Loxapine—Hypersensitivity—Enalapril—coronary artery disease	9.1e-05	0.000652	CcSEcCtD
Loxapine—Headache—Eplerenone—coronary artery disease	9.09e-05	0.000651	CcSEcCtD
Loxapine—Nervous system disorder—Ramipril—coronary artery disease	9.08e-05	0.00065	CcSEcCtD
Loxapine—Thrombocytopenia—Ramipril—coronary artery disease	9.06e-05	0.000649	CcSEcCtD
Loxapine—Oedema—Timolol—coronary artery disease	9.05e-05	0.000648	CcSEcCtD
Loxapine—Pruritus—Pravastatin—coronary artery disease	9.04e-05	0.000648	CcSEcCtD
Loxapine—Loss of consciousness—Lisinopril—coronary artery disease	9.04e-05	0.000648	CcSEcCtD
Loxapine—Nausea—Clopidogrel—coronary artery disease	9.03e-05	0.000647	CcSEcCtD
Loxapine—Tachycardia—Ramipril—coronary artery disease	9.03e-05	0.000647	CcSEcCtD
Loxapine—Vomiting—Simvastatin—coronary artery disease	8.99e-05	0.000644	CcSEcCtD
Loxapine—Hypersensitivity—Telmisartan—coronary artery disease	8.98e-05	0.000644	CcSEcCtD
Loxapine—Cough—Lisinopril—coronary artery disease	8.97e-05	0.000643	CcSEcCtD
Loxapine—Nausea—Lovastatin—coronary artery disease	8.97e-05	0.000643	CcSEcCtD
Loxapine—Rash—Simvastatin—coronary artery disease	8.91e-05	0.000639	CcSEcCtD
Loxapine—Dermatitis—Simvastatin—coronary artery disease	8.9e-05	0.000638	CcSEcCtD
Loxapine—Asthenia—Trandolapril—coronary artery disease	8.9e-05	0.000638	CcSEcCtD
Loxapine—Shock—Timolol—coronary artery disease	8.9e-05	0.000638	CcSEcCtD
Loxapine—Feeling abnormal—Losartan—coronary artery disease	8.89e-05	0.000637	CcSEcCtD
Loxapine—Nervous system disorder—Timolol—coronary artery disease	8.87e-05	0.000636	CcSEcCtD
Loxapine—Asthenia—Enalapril—coronary artery disease	8.87e-05	0.000635	CcSEcCtD
Loxapine—Headache—Simvastatin—coronary artery disease	8.85e-05	0.000634	CcSEcCtD
Loxapine—Dizziness—Valsartan—coronary artery disease	8.83e-05	0.000632	CcSEcCtD
Loxapine—Nausea—Ezetimibe—coronary artery disease	8.8e-05	0.000631	CcSEcCtD
Loxapine—Dizziness—Olmesartan—coronary artery disease	8.78e-05	0.000629	CcSEcCtD
Loxapine—Pruritus—Trandolapril—coronary artery disease	8.78e-05	0.000629	CcSEcCtD
Loxapine—Chest pain—Lisinopril—coronary artery disease	8.76e-05	0.000627	CcSEcCtD
Loxapine—Asthenia—Telmisartan—coronary artery disease	8.75e-05	0.000627	CcSEcCtD
Loxapine—Pruritus—Enalapril—coronary artery disease	8.74e-05	0.000627	CcSEcCtD
Loxapine—Azelastine—CYP2C19—coronary artery disease	8.7e-05	0.0229	CrCbGaD
Loxapine—Hypotension—Ramipril—coronary artery disease	8.65e-05	0.00062	CcSEcCtD
Loxapine—Pruritus—Telmisartan—coronary artery disease	8.62e-05	0.000618	CcSEcCtD
Loxapine—Nausea—Eplerenone—coronary artery disease	8.62e-05	0.000617	CcSEcCtD
Loxapine—Dizziness—Niacin—coronary artery disease	8.58e-05	0.000615	CcSEcCtD
Loxapine—Dry mouth—Lisinopril—coronary artery disease	8.56e-05	0.000614	CcSEcCtD
Loxapine—Asthenia—Captopril—coronary artery disease	8.5e-05	0.000609	CcSEcCtD
Loxapine—Vomiting—Valsartan—coronary artery disease	8.49e-05	0.000608	CcSEcCtD
Loxapine—Confusional state—Lisinopril—coronary artery disease	8.46e-05	0.000607	CcSEcCtD
Loxapine—Hypotension—Timolol—coronary artery disease	8.45e-05	0.000606	CcSEcCtD
Loxapine—Dizziness—Pravastatin—coronary artery disease	8.45e-05	0.000605	CcSEcCtD
Loxapine—Vomiting—Olmesartan—coronary artery disease	8.44e-05	0.000605	CcSEcCtD
Loxapine—Rash—Valsartan—coronary artery disease	8.41e-05	0.000603	CcSEcCtD
Loxapine—Dermatitis—Valsartan—coronary artery disease	8.41e-05	0.000602	CcSEcCtD
Loxapine—Nausea—Simvastatin—coronary artery disease	8.39e-05	0.000602	CcSEcCtD
Loxapine—Oedema—Lisinopril—coronary artery disease	8.39e-05	0.000602	CcSEcCtD
Loxapine—Pruritus—Captopril—coronary artery disease	8.39e-05	0.000601	CcSEcCtD
Loxapine—Rash—Olmesartan—coronary artery disease	8.37e-05	0.0006	CcSEcCtD
Loxapine—Insomnia—Ramipril—coronary artery disease	8.37e-05	0.0006	CcSEcCtD
Loxapine—Dermatitis—Olmesartan—coronary artery disease	8.37e-05	0.0006	CcSEcCtD
Loxapine—Headache—Valsartan—coronary artery disease	8.36e-05	0.000599	CcSEcCtD
Loxapine—Headache—Olmesartan—coronary artery disease	8.32e-05	0.000596	CcSEcCtD
Loxapine—Paraesthesia—Ramipril—coronary artery disease	8.31e-05	0.000596	CcSEcCtD
Loxapine—Shock—Lisinopril—coronary artery disease	8.26e-05	0.000592	CcSEcCtD
Loxapine—Asthenia—Perindopril—coronary artery disease	8.26e-05	0.000592	CcSEcCtD
Loxapine—Dyspnoea—Ramipril—coronary artery disease	8.25e-05	0.000591	CcSEcCtD
Loxapine—Vomiting—Niacin—coronary artery disease	8.25e-05	0.000591	CcSEcCtD
Loxapine—Hypersensitivity—Furosemide—coronary artery disease	8.24e-05	0.000591	CcSEcCtD
Loxapine—Somnolence—Ramipril—coronary artery disease	8.23e-05	0.00059	CcSEcCtD
Loxapine—Thrombocytopenia—Lisinopril—coronary artery disease	8.22e-05	0.000589	CcSEcCtD
Loxapine—Dizziness—Trandolapril—coronary artery disease	8.2e-05	0.000588	CcSEcCtD
Loxapine—Tachycardia—Lisinopril—coronary artery disease	8.19e-05	0.000587	CcSEcCtD
Loxapine—Insomnia—Timolol—coronary artery disease	8.18e-05	0.000586	CcSEcCtD
Loxapine—Rash—Niacin—coronary artery disease	8.18e-05	0.000586	CcSEcCtD
Loxapine—Dermatitis—Niacin—coronary artery disease	8.17e-05	0.000586	CcSEcCtD
Loxapine—Dizziness—Enalapril—coronary artery disease	8.17e-05	0.000586	CcSEcCtD
Loxapine—Pruritus—Perindopril—coronary artery disease	8.14e-05	0.000583	CcSEcCtD
Loxapine—Headache—Niacin—coronary artery disease	8.13e-05	0.000583	CcSEcCtD
Loxapine—Paraesthesia—Timolol—coronary artery disease	8.12e-05	0.000582	CcSEcCtD
Loxapine—Vomiting—Pravastatin—coronary artery disease	8.12e-05	0.000582	CcSEcCtD
Loxapine—Dyspnoea—Timolol—coronary artery disease	8.07e-05	0.000578	CcSEcCtD
Loxapine—Dizziness—Telmisartan—coronary artery disease	8.06e-05	0.000578	CcSEcCtD
Loxapine—Rash—Pravastatin—coronary artery disease	8.06e-05	0.000577	CcSEcCtD
Loxapine—Dermatitis—Pravastatin—coronary artery disease	8.05e-05	0.000577	CcSEcCtD
Loxapine—Somnolence—Timolol—coronary artery disease	8.04e-05	0.000576	CcSEcCtD
Loxapine—Asthenia—Furosemide—coronary artery disease	8.03e-05	0.000575	CcSEcCtD
Loxapine—Headache—Pravastatin—coronary artery disease	8e-05	0.000574	CcSEcCtD
Loxapine—Gastrointestinal disorder—Ramipril—coronary artery disease	7.99e-05	0.000573	CcSEcCtD
Loxapine—Fatigue—Ramipril—coronary artery disease	7.98e-05	0.000572	CcSEcCtD
Loxapine—Hypersensitivity—Losartan—coronary artery disease	7.95e-05	0.00057	CcSEcCtD
Loxapine—Nausea—Valsartan—coronary artery disease	7.93e-05	0.000568	CcSEcCtD
Loxapine—Pruritus—Furosemide—coronary artery disease	7.91e-05	0.000567	CcSEcCtD
Loxapine—Constipation—Ramipril—coronary artery disease	7.91e-05	0.000567	CcSEcCtD
Loxapine—Nausea—Olmesartan—coronary artery disease	7.89e-05	0.000565	CcSEcCtD
Loxapine—Vomiting—Trandolapril—coronary artery disease	7.89e-05	0.000565	CcSEcCtD
Loxapine—Vomiting—Enalapril—coronary artery disease	7.86e-05	0.000563	CcSEcCtD
Loxapine—Hypotension—Lisinopril—coronary artery disease	7.84e-05	0.000562	CcSEcCtD
Loxapine—Dizziness—Captopril—coronary artery disease	7.84e-05	0.000562	CcSEcCtD
Loxapine—Rash—Trandolapril—coronary artery disease	7.82e-05	0.000561	CcSEcCtD
Loxapine—Dermatitis—Trandolapril—coronary artery disease	7.82e-05	0.00056	CcSEcCtD
Loxapine—Gastrointestinal disorder—Timolol—coronary artery disease	7.81e-05	0.00056	CcSEcCtD
Loxapine—Fatigue—Timolol—coronary artery disease	7.8e-05	0.000559	CcSEcCtD
Loxapine—Rash—Enalapril—coronary artery disease	7.79e-05	0.000558	CcSEcCtD
Loxapine—Dermatitis—Enalapril—coronary artery disease	7.78e-05	0.000558	CcSEcCtD
Loxapine—Headache—Trandolapril—coronary artery disease	7.77e-05	0.000557	CcSEcCtD
Loxapine—Vomiting—Telmisartan—coronary artery disease	7.75e-05	0.000555	CcSEcCtD
Loxapine—Asthenia—Losartan—coronary artery disease	7.74e-05	0.000555	CcSEcCtD
Loxapine—Headache—Enalapril—coronary artery disease	7.74e-05	0.000555	CcSEcCtD
Loxapine—Nausea—Niacin—coronary artery disease	7.71e-05	0.000552	CcSEcCtD
Loxapine—Rash—Telmisartan—coronary artery disease	7.69e-05	0.000551	CcSEcCtD
Loxapine—Dermatitis—Telmisartan—coronary artery disease	7.68e-05	0.00055	CcSEcCtD
Loxapine—Pruritus—Losartan—coronary artery disease	7.64e-05	0.000547	CcSEcCtD
Loxapine—Headache—Telmisartan—coronary artery disease	7.64e-05	0.000547	CcSEcCtD
Loxapine—Feeling abnormal—Ramipril—coronary artery disease	7.63e-05	0.000547	CcSEcCtD
Loxapine—Dizziness—Perindopril—coronary artery disease	7.61e-05	0.000545	CcSEcCtD
Loxapine—Insomnia—Lisinopril—coronary artery disease	7.59e-05	0.000544	CcSEcCtD
Loxapine—Nausea—Pravastatin—coronary artery disease	7.59e-05	0.000544	CcSEcCtD
Loxapine—Paraesthesia—Lisinopril—coronary artery disease	7.54e-05	0.00054	CcSEcCtD
Loxapine—Vomiting—Captopril—coronary artery disease	7.54e-05	0.00054	CcSEcCtD
Loxapine—Dyspnoea—Lisinopril—coronary artery disease	7.48e-05	0.000536	CcSEcCtD
Loxapine—Rash—Captopril—coronary artery disease	7.47e-05	0.000536	CcSEcCtD
Loxapine—Olanzapine—CYP2C19—coronary artery disease	7.47e-05	0.0197	CrCbGaD
Loxapine—Dermatitis—Captopril—coronary artery disease	7.47e-05	0.000535	CcSEcCtD
Loxapine—Somnolence—Lisinopril—coronary artery disease	7.46e-05	0.000535	CcSEcCtD
Loxapine—Feeling abnormal—Timolol—coronary artery disease	7.46e-05	0.000534	CcSEcCtD
Loxapine—Headache—Captopril—coronary artery disease	7.43e-05	0.000532	CcSEcCtD
Loxapine—Dizziness—Furosemide—coronary artery disease	7.4e-05	0.00053	CcSEcCtD
Loxapine—Nausea—Trandolapril—coronary artery disease	7.37e-05	0.000528	CcSEcCtD
Loxapine—Nausea—Enalapril—coronary artery disease	7.34e-05	0.000526	CcSEcCtD
Loxapine—Vomiting—Perindopril—coronary artery disease	7.32e-05	0.000524	CcSEcCtD
Loxapine—Quetiapine—HTR7—coronary artery disease	7.31e-05	0.0192	CrCbGaD
Loxapine—Rash—Perindopril—coronary artery disease	7.26e-05	0.00052	CcSEcCtD
Loxapine—Dermatitis—Perindopril—coronary artery disease	7.25e-05	0.000519	CcSEcCtD
Loxapine—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.25e-05	0.000519	CcSEcCtD
Loxapine—Nausea—Telmisartan—coronary artery disease	7.24e-05	0.000519	CcSEcCtD
Loxapine—Fatigue—Lisinopril—coronary artery disease	7.24e-05	0.000519	CcSEcCtD
Loxapine—Headache—Perindopril—coronary artery disease	7.21e-05	0.000517	CcSEcCtD
Loxapine—Constipation—Lisinopril—coronary artery disease	7.18e-05	0.000514	CcSEcCtD
Loxapine—Dizziness—Losartan—coronary artery disease	7.14e-05	0.000512	CcSEcCtD
Loxapine—Vomiting—Furosemide—coronary artery disease	7.11e-05	0.00051	CcSEcCtD
Loxapine—Rash—Furosemide—coronary artery disease	7.05e-05	0.000505	CcSEcCtD
Loxapine—Dermatitis—Furosemide—coronary artery disease	7.05e-05	0.000505	CcSEcCtD
Loxapine—Nausea—Captopril—coronary artery disease	7.04e-05	0.000505	CcSEcCtD
Loxapine—Headache—Furosemide—coronary artery disease	7.01e-05	0.000502	CcSEcCtD
Loxapine—Feeling abnormal—Lisinopril—coronary artery disease	6.92e-05	0.000496	CcSEcCtD
Loxapine—Vomiting—Losartan—coronary artery disease	6.86e-05	0.000492	CcSEcCtD
Loxapine—Nausea—Perindopril—coronary artery disease	6.84e-05	0.00049	CcSEcCtD
Loxapine—Hypersensitivity—Ramipril—coronary artery disease	6.82e-05	0.000489	CcSEcCtD
Loxapine—Rash—Losartan—coronary artery disease	6.81e-05	0.000488	CcSEcCtD
Loxapine—Dermatitis—Losartan—coronary artery disease	6.8e-05	0.000487	CcSEcCtD
Loxapine—Clobazam—CYP2C19—coronary artery disease	6.77e-05	0.0178	CrCbGaD
Loxapine—Headache—Losartan—coronary artery disease	6.76e-05	0.000485	CcSEcCtD
Loxapine—Hypersensitivity—Timolol—coronary artery disease	6.67e-05	0.000478	CcSEcCtD
Loxapine—Nausea—Furosemide—coronary artery disease	6.64e-05	0.000476	CcSEcCtD
Loxapine—Asthenia—Ramipril—coronary artery disease	6.64e-05	0.000476	CcSEcCtD
Loxapine—Pruritus—Ramipril—coronary artery disease	6.55e-05	0.000469	CcSEcCtD
Loxapine—Asthenia—Timolol—coronary artery disease	6.49e-05	0.000465	CcSEcCtD
Loxapine—Nausea—Losartan—coronary artery disease	6.41e-05	0.000459	CcSEcCtD
Loxapine—Pruritus—Timolol—coronary artery disease	6.4e-05	0.000459	CcSEcCtD
Loxapine—Zuclopenthixol—HTR2A—coronary artery disease	6.36e-05	0.0167	CrCbGaD
Loxapine—Clozapine—HTR7—coronary artery disease	6.29e-05	0.0165	CrCbGaD
Loxapine—Cyproheptadine—HTR2A—coronary artery disease	6.25e-05	0.0165	CrCbGaD
Loxapine—Hypersensitivity—Lisinopril—coronary artery disease	6.18e-05	0.000443	CcSEcCtD
Loxapine—Dizziness—Ramipril—coronary artery disease	6.12e-05	0.000439	CcSEcCtD
Loxapine—Olanzapine—HTR2A—coronary artery disease	6.06e-05	0.0159	CrCbGaD
Loxapine—Asthenia—Lisinopril—coronary artery disease	6.02e-05	0.000432	CcSEcCtD
Loxapine—Dizziness—Timolol—coronary artery disease	5.98e-05	0.000429	CcSEcCtD
Loxapine—Pruritus—Lisinopril—coronary artery disease	5.94e-05	0.000426	CcSEcCtD
Loxapine—Vomiting—Ramipril—coronary artery disease	5.88e-05	0.000422	CcSEcCtD
Loxapine—Trazodone—HTR2A—coronary artery disease	5.85e-05	0.0154	CrCbGaD
Loxapine—Rash—Ramipril—coronary artery disease	5.84e-05	0.000418	CcSEcCtD
Loxapine—Dermatitis—Ramipril—coronary artery disease	5.83e-05	0.000418	CcSEcCtD
Loxapine—Headache—Ramipril—coronary artery disease	5.8e-05	0.000416	CcSEcCtD
Loxapine—Vomiting—Timolol—coronary artery disease	5.75e-05	0.000412	CcSEcCtD
Loxapine—Rash—Timolol—coronary artery disease	5.7e-05	0.000409	CcSEcCtD
Loxapine—Dermatitis—Timolol—coronary artery disease	5.7e-05	0.000408	CcSEcCtD
Loxapine—Headache—Timolol—coronary artery disease	5.67e-05	0.000406	CcSEcCtD
Loxapine—Dizziness—Lisinopril—coronary artery disease	5.55e-05	0.000398	CcSEcCtD
Loxapine—Nausea—Ramipril—coronary artery disease	5.5e-05	0.000394	CcSEcCtD
Loxapine—Thiothixene—HTR2A—coronary artery disease	5.48e-05	0.0144	CrCbGaD
Loxapine—Nausea—Timolol—coronary artery disease	5.37e-05	0.000385	CcSEcCtD
Loxapine—Vomiting—Lisinopril—coronary artery disease	5.34e-05	0.000382	CcSEcCtD
Loxapine—Rash—Lisinopril—coronary artery disease	5.29e-05	0.000379	CcSEcCtD
Loxapine—Dermatitis—Lisinopril—coronary artery disease	5.29e-05	0.000379	CcSEcCtD
Loxapine—Headache—Lisinopril—coronary artery disease	5.26e-05	0.000377	CcSEcCtD
Loxapine—Nausea—Lisinopril—coronary artery disease	4.99e-05	0.000357	CcSEcCtD
Loxapine—Amoxapine—HTR2A—coronary artery disease	4.82e-05	0.0127	CrCbGaD
Loxapine—Temazepam—CYP2C19—coronary artery disease	4.75e-05	0.0125	CrCbGaD
Loxapine—Quetiapine—CYP2C19—coronary artery disease	4.53e-05	0.0119	CrCbGaD
Loxapine—Olanzapine—ALB—coronary artery disease	4.15e-05	0.0109	CrCbGaD
Loxapine—Diazepam—CYP2C19—coronary artery disease	3.95e-05	0.0104	CrCbGaD
Loxapine—Clozapine—CYP2C19—coronary artery disease	3.9e-05	0.0103	CrCbGaD
Loxapine—Trifluoperazine—HTR2A—coronary artery disease	3.79e-05	0.00997	CrCbGaD
Loxapine—Thiothixene—ALB—coronary artery disease	3.75e-05	0.00987	CrCbGaD
Loxapine—Quetiapine—HTR2A—coronary artery disease	3.68e-05	0.00967	CrCbGaD
Loxapine—Clozapine—HTR2A—coronary artery disease	3.16e-05	0.00832	CrCbGaD
Loxapine—Diazepam—ALB—coronary artery disease	2.19e-05	0.00576	CrCbGaD
Loxapine—ADRB1—Signaling Pathways—CCND1—coronary artery disease	8.7e-07	5.69e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	8.7e-07	5.69e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	8.69e-07	5.68e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOS3—coronary artery disease	8.68e-07	5.68e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	8.66e-07	5.66e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTGS2—coronary artery disease	8.65e-07	5.66e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	8.65e-07	5.66e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	8.64e-07	5.65e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	8.63e-07	5.65e-06	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	8.63e-07	5.64e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	8.62e-07	5.64e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	8.62e-07	5.64e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TGFB1—coronary artery disease	8.6e-07	5.62e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—JAK2—coronary artery disease	8.59e-07	5.62e-06	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	8.58e-07	5.61e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	8.57e-07	5.61e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CASP3—coronary artery disease	8.55e-07	5.59e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	8.54e-07	5.59e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	8.52e-07	5.57e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	8.5e-07	5.56e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	8.5e-07	5.56e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—IL6—coronary artery disease	8.49e-07	5.55e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TGFB1—coronary artery disease	8.48e-07	5.55e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	8.45e-07	5.53e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	8.45e-07	5.53e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MMP9—coronary artery disease	8.44e-07	5.52e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—JAK2—coronary artery disease	8.43e-07	5.52e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—VEGFA—coronary artery disease	8.43e-07	5.52e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MAPK1—coronary artery disease	8.43e-07	5.52e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	8.42e-07	5.51e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	8.41e-07	5.5e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	8.38e-07	5.48e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	8.37e-07	5.47e-06	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	8.35e-07	5.46e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—VEGFA—coronary artery disease	8.32e-07	5.44e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CCND1—coronary artery disease	8.32e-07	5.44e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MAPK1—coronary artery disease	8.32e-07	5.44e-06	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	8.3e-07	5.43e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	8.3e-07	5.43e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	8.29e-07	5.42e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	8.28e-07	5.42e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	8.28e-07	5.41e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	8.28e-07	5.41e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	8.27e-07	5.41e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	8.27e-07	5.41e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	8.24e-07	5.39e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	8.22e-07	5.37e-06	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	8.22e-07	5.37e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	8.21e-07	5.37e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	8.19e-07	5.36e-06	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—AKT1—coronary artery disease	8.15e-07	5.33e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	8.14e-07	5.32e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	8.13e-07	5.32e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	8.12e-07	5.31e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	8.11e-07	5.31e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	8.11e-07	5.31e-06	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—AKT1—coronary artery disease	8.1e-07	5.3e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	8.09e-07	5.29e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MMP9—coronary artery disease	8.08e-07	5.28e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	8.05e-07	5.27e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	8.04e-07	5.26e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	8.02e-07	5.25e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	7.97e-07	5.21e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	7.92e-07	5.18e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	7.91e-07	5.18e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	7.84e-07	5.13e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	7.83e-07	5.12e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	7.82e-07	5.11e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	7.79e-07	5.1e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TGFB1—coronary artery disease	7.74e-07	5.06e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	7.71e-07	5.05e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	7.7e-07	5.03e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	7.69e-07	5.03e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	7.69e-07	5.03e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	7.67e-07	5.02e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	7.65e-07	5.01e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	7.65e-07	5e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	7.64e-07	5e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TGFB1—coronary artery disease	7.64e-07	5e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	7.59e-07	4.97e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MAPK1—coronary artery disease	7.59e-07	4.97e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	7.58e-07	4.96e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	7.58e-07	4.96e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	7.57e-07	4.95e-06	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	7.57e-07	4.95e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	7.55e-07	4.94e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	7.54e-07	4.93e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	7.51e-07	4.91e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CASP3—coronary artery disease	7.5e-07	4.91e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MAPK1—coronary artery disease	7.49e-07	4.9e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	7.46e-07	4.88e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—IL6—coronary artery disease	7.46e-07	4.88e-06	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	7.45e-07	4.87e-06	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	7.44e-07	4.86e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	7.44e-07	4.86e-06	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	7.41e-07	4.85e-06	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	7.39e-07	4.83e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	7.38e-07	4.83e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CASP3—coronary artery disease	7.37e-07	4.82e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	7.34e-07	4.8e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	7.34e-07	4.8e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	7.32e-07	4.79e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—IL6—coronary artery disease	7.32e-07	4.79e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	7.32e-07	4.79e-06	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	7.32e-07	4.79e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CCND1—coronary artery disease	7.3e-07	4.78e-06	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	7.3e-07	4.77e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	7.3e-07	4.77e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	7.27e-07	4.76e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	7.25e-07	4.74e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	7.25e-07	4.74e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	7.23e-07	4.73e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	7.22e-07	4.72e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	7.22e-07	4.72e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	7.2e-07	4.71e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	7.19e-07	4.7e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	7.18e-07	4.7e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CCND1—coronary artery disease	7.17e-07	4.69e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	7.15e-07	4.68e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	7.13e-07	4.66e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MMP9—coronary artery disease	7.09e-07	4.64e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	7.06e-07	4.62e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	7.04e-07	4.6e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	7.02e-07	4.59e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	7.02e-07	4.59e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	6.98e-07	4.56e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MMP9—coronary artery disease	6.96e-07	4.55e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	6.96e-07	4.55e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	6.94e-07	4.54e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	6.92e-07	4.52e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	6.91e-07	4.52e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	6.91e-07	4.52e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	6.9e-07	4.51e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	6.88e-07	4.5e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	6.85e-07	4.48e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	6.83e-07	4.47e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	6.82e-07	4.46e-06	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	6.78e-07	4.43e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—IL6—coronary artery disease	6.78e-07	4.43e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—IL6—coronary artery disease	6.77e-07	4.43e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	6.77e-07	4.43e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	6.76e-07	4.42e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	6.75e-07	4.42e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	6.73e-07	4.4e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—IL6—coronary artery disease	6.72e-07	4.4e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	6.72e-07	4.39e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	6.71e-07	4.39e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	6.67e-07	4.37e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	6.66e-07	4.35e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	6.64e-07	4.35e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	6.63e-07	4.33e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	6.62e-07	4.33e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	6.59e-07	4.31e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IL6—coronary artery disease	6.58e-07	4.31e-06	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—PIK3CA—coronary artery disease	6.56e-07	4.29e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	6.54e-07	4.28e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	6.53e-07	4.27e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	6.5e-07	4.25e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	6.49e-07	4.25e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IL6—coronary artery disease	6.48e-07	4.24e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	6.44e-07	4.21e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IL6—coronary artery disease	6.39e-07	4.18e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	6.37e-07	4.17e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	6.35e-07	4.15e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	6.34e-07	4.15e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	6.32e-07	4.13e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	6.27e-07	4.1e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	6.25e-07	4.09e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—AKT1—coronary artery disease	6.25e-07	4.09e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—AKT1—coronary artery disease	6.24e-07	4.08e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	6.23e-07	4.08e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	6.22e-07	4.07e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	6.21e-07	4.06e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—AKT1—coronary artery disease	6.2e-07	4.06e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	6.16e-07	4.03e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	6.15e-07	4.02e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	6.14e-07	4.01e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL6—coronary artery disease	6.12e-07	4e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—AKT1—coronary artery disease	6.07e-07	3.97e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—AKT1—coronary artery disease	5.98e-07	3.91e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	5.92e-07	3.87e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—AKT1—coronary artery disease	5.9e-07	3.86e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	5.87e-07	3.84e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	5.84e-07	3.82e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL6—coronary artery disease	5.83e-07	3.82e-06	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PIK3CA—coronary artery disease	5.8e-07	3.8e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL6—coronary artery disease	5.76e-07	3.76e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	5.75e-07	3.76e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	5.74e-07	3.75e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	5.73e-07	3.75e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	5.72e-07	3.74e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	5.7e-07	3.73e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	5.7e-07	3.73e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	5.66e-07	3.71e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—AKT1—coronary artery disease	5.65e-07	3.69e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	5.65e-07	3.69e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	5.64e-07	3.69e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	5.64e-07	3.69e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	5.63e-07	3.68e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	5.63e-07	3.68e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	5.61e-07	3.67e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	5.59e-07	3.66e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	5.54e-07	3.62e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	5.52e-07	3.61e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	5.48e-07	3.59e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	5.39e-07	3.53e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—AKT1—coronary artery disease	5.38e-07	3.52e-06	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—AKT1—coronary artery disease	5.36e-07	3.5e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	5.32e-07	3.48e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—AKT1—coronary artery disease	5.31e-07	3.47e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL6—coronary artery disease	5.24e-07	3.43e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	5.23e-07	3.42e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	5.2e-07	3.4e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	5.13e-07	3.36e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL6—coronary artery disease	5.02e-07	3.28e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL6—coronary artery disease	4.99e-07	3.26e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	4.97e-07	3.25e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	4.89e-07	3.2e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	4.88e-07	3.19e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	4.87e-07	3.18e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL6—coronary artery disease	4.85e-07	3.17e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	4.85e-07	3.17e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—AKT1—coronary artery disease	4.84e-07	3.16e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	4.8e-07	3.14e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	4.79e-07	3.14e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	4.79e-07	3.13e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	4.78e-07	3.12e-06	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—AKT1—coronary artery disease	4.74e-07	3.1e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	4.63e-07	3.03e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	4.6e-07	3.01e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	4.48e-07	2.93e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	4.45e-07	2.91e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	4.41e-07	2.88e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL6—coronary artery disease	4.4e-07	2.88e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—AKT1—coronary artery disease	4.35e-07	2.85e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL6—coronary artery disease	4.33e-07	2.83e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL6—coronary artery disease	4.32e-07	2.83e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL6—coronary artery disease	4.31e-07	2.82e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL6—coronary artery disease	4.3e-07	2.81e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL6—coronary artery disease	4.25e-07	2.78e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	4.24e-07	2.78e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—AKT1—coronary artery disease	4.06e-07	2.66e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	4e-07	2.61e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—AKT1—coronary artery disease	3.99e-07	2.61e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	3.98e-07	2.6e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	3.96e-07	2.59e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	3.94e-07	2.58e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	3.93e-07	2.57e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	3.91e-07	2.56e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	3.64e-07	2.38e-06	CbGpPWpGaD
